Profile
TMBR VRTX REGN VRNA ARGX ALNY
Company Name Timber Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $1.18M $116.75B $76.56B $72.68B $52.08B $51.68B
Employees 0.01K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO John Koconis Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
TMBR VRTX REGN VRNA ARGX ALNY
Quant Rating Score 3 4 4 1 4 3
Quant Rating Neutral Buy Buy Strong Sell Buy Neutral
Trading
TMBR VRTX REGN VRNA ARGX ALNY
Last Close $0.3426 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $0.34 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.34 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High 0.76 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 0.76 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
TMBR VRTX REGN VRNA ARGX ALNY
1 Month Return 0 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 0 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 0 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 0 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 0 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 0 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TMBR VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -2238.13 % 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.06 % - - -
Profitability
TMBR VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM -15892.35 % 86.28 % 85.39 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -188.59 % 14.78 % 11.4 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -209.49 % 19.62 % 15.31 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -367.47 % 19.59 % 10.32 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100.04 % 82.61 % 88.98 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 100.71 % 111.4 % 139.5 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -23125.86 % 34.06 % 25.89 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -4787.81 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.51 1.93 1.91 3.33
Payables Turnover TTM 9.85 0.4 2.3 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.64 0.94 2.26 6.82
Fixed Asset Turnover TTM 24.81 % 388.59 % 284.82 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 0.81 % 47.15 % 35.47 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -7.52 14.55 48.94 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -7.52 13.06 40.09 -0.85 5.58 1.68
Cash Per Share TTM 430.73 % 2459.7 % 8148.65 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -19061.66 % 31.71 % 35.59 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.04 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -4787.81 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.07 34.99 18.43 -995.27 133.11 233.46
Price To Operating Cash Flows Ratio TTM -0.05 31.28 15.15 -126.33 152.03 193.4
Price Cash Flow Ratio TTM -0.05 31.28 15.15 -126.33 152.03 193.4
Income Statement (TTM)
TMBR VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.2B $0.03B $2.19B $2.25B
Gross Profit $-0.01B $9.49B $12.23B $0.03B $1.96B $1.92B
Gross Profit Ratio -15892.35% 86.11% 86.13% 93.89% 89.62% 85.62%
EBITDA $-0.02B $0.49B $5.32B $-0.12B $0.11B $-0.18B
Net Income $-0.02B $-0.54B $4.41B $-0.14B $0.83B $-0.28B
EPS Diluted -9.19 -2.08 38.34 -1.73 12.78 -2.18
Balance Sheet (MRQ)
TMBR VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.7B $0.12B $0.03B $2.59B
Total Liabilities $0.01B $6.12B $8.41B $0.27B $0.7B $4.17B
Total Equity $0.01B $16.41B $29.35B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.7B $0.12B $0.04B $2.74B
Total Assets $0.01B $22.53B $37.76B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
TMBR VRTX REGN VRNA ARGX ALNY
Net Income $-0.02B $-0.54B $4.41B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.42B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 29.21
AARD Aardvark Therapeutics, Inc. Common Stock 13.54
ABCL AbCellera Biologics Inc. 3.395
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.88
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.055
ABPWW 0.014
ABSI Absci Corporation 3.4463
ABUS Arbutus Biopharma Corporation 4.635
ABVC ABVC BioPharma, Inc. 2.07
ABVX Abivax SA American Depositary Shares 111.116
ACAD ACADIA Pharmaceuticals Inc. 27.168
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.48
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.265
ACIU AC Immune SA 3.0526
ETFs With Exposure to TMBR
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 146.415
Unlock